Name | Title | Contact Details |
---|---|---|
Christopher Blanchette |
Vice President and Head, Clinical Development and Outcomes Research, NNI | Profile |
John McDonald |
Corporate Vice President, Global R&D Business Development | Profile |
Jill Branca Priselac |
VP, R&D Business Development | Profile |
Benjamin Soule |
Senior Medical Director, NASH - Clinical Development and Research, NNI | Profile |
Rahul Ganguly |
Vice President, Clinical Development & Outcomes Research | Profile |
Curie Therapeutics is a fully integrated, next-generation radiopharmaceuticals company focused on pioneering a new class of targeted radiopharmaceuticals that are both safe and effective. Curie`s radiopharmaceuticals are composed of rationally designed conjugates against carefully selected biological targets, to deliver alpha and beta-emitting radionuclide payloads. Curie`s mission is to revolutionize the use of radiomedicines in cancer.
Sagent Pharmaceuticals is a Schaumburg, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Novel therapeutics for metabolic and endocrine disorders
Morris & Dickson Co. is a Shreveport, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sleep Prescription is a Rancho Santa Margarita, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.